HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathophysiological role of endothelins in pulmonary microcirculatory disorders due to intestinal ischemia and reperfusion.

AbstractBACKGROUND:
This study was conducted to investigate pulmonary microcirculatory disorders caused by intestinal ischemia reperfusion (IIR), and the pathophysiological roles of endothelin (ET) in acute lung injury (ALI).
METHODS:
Male rats were pretreated with normal saline or a nonselective ET receptor antagonist (TAK-044) and subjected to IIR (60 min of intestinal ischemia and 180 min of reperfusion). The right upper lobe of the lung was examined by intravital confocal microscopy.
RESULTS:
The size of arterioles and venules was not significantly reduced during IIR, but the functional capillary density (FCD) decreased significantly. TAK-044 improved the pulmonary microhemodynamics, inhibiting the accumulation of leukocytes, the pulmonary edema, and the decrease of FCD.
CONCLUSIONS:
In the early stage of IIR, pulmonary microhemodynamics seemed more likely to be disturbed by the decrease of FCD, than by arteriolar or venular vasoconstriction. ETs decrease the FCD, promoting the interaction between leukocytes and pulmonary vessels.
AuthorsH Mitsuoka, N Unno, T Sakurai, H Kaneko, S Suzuki, H Konno, S Terakawa, S Nakamura
JournalThe Journal of surgical research (J Surg Res) Vol. 87 Issue 2 Pg. 143-51 (Dec 1999) ISSN: 0022-4804 [Print] United States
PMID10600343 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 1999 Academic Press.
Chemical References
  • Endothelins
  • Peptides, Cyclic
  • TAK 044
Topics
  • Animals
  • Endothelins (physiology)
  • Hemodynamics (drug effects)
  • Intestines (blood supply)
  • Ischemia (physiopathology)
  • Male
  • Microcirculation
  • Neutrophils (physiology)
  • Peptides, Cyclic (pharmacology)
  • Pulmonary Circulation
  • Pulmonary Edema (etiology)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: